Microarray-based detection of genetic heterogeneity, antimicrobial resistance, and the viable but nonculturable state in human pathogenic Vibrio spp.

Gary J. Vora, Carolyn E. Meador, Michele M. Bird, Cheryl A. Bopp, Joanne D. Andreadis, David A. StengerProceedings of the National Academy of Sciences 2005 · DOI

TL;DR

This paper introduces a novel microarray-based platform that uses a multiplex PCR assay to simultaneously detect the genetic makeup, antimicrobial resistance, and virulence factors of pathogenic Vibrio species. Crucially, it can also identify these bacteria even when they are in a viable but nonculturable (VBNC) state, offering a significant advancement for rapid and comprehensive pathogen surveillance.

What Problem Does This Paper Address?

Waterborne diseases caused by Vibrio species, such as cholera, pose a significant public health threat. Traditional methods for identifying these pathogens, like culturing and biochemical tests, are slow, labor-intensive, and often fail to provide a complete picture of a bacterium's potential to cause harm. These methods can also miss Vibrio in a viable but nonculturable (VBNC) state, a survival mechanism where bacteria are metabolically active but cannot be grown on standard media, yet can still cause disease. Furthermore, the ability of Vibrio to acquire mobile genetic elements carrying antibiotic resistance and virulence genes complicates identification and risk assessment. This paper aims to address these limitations by developing a rapid, comprehensive molecular detection system.

Methods

The core of this research is a combined approach using a multiplex PCR assay and a long oligonucleotide DNA microarray.

  1. Multiplex PCR Assay: A single PCR reaction was designed to amplify 95 different DNA regions simultaneously. These regions are specific for:
  2. Vibrio species and serogroups.
  3. Antimicrobial resistance genes.
  4. Known toxin and virulence markers.
  5. Mobile genetic elements (like integrons).
  6. Oligonucleotide Microarray: The amplified DNA fragments (labeled with Cy5-dCTP) are then hybridized to a microarray containing complementary probes for each of the 95 targets. The binding of amplified DNA to these probes generates a signal, allowing for the simultaneous detection of multiple genetic markers.
  7. VBNC Detection: To detect VBNC Vibrio, the researchers adapted the method to analyze RNA instead of DNA. By extracting RNA from nonculturable bacterial samples and performing RT-PCR followed by microarray hybridization, they could assess which genes were actively being expressed, indicating viability and potential pathogenicity.

Datasets

The study utilized a collection of 100 Vibrio isolates, primarily clinical in origin, collected between 1921 and 2004. These isolates were previously identified and characterized using standard methods. The researchers also generated data from experimental cultures of VBNC Vibrio strains.

Key Insights and Ideas

  • Simultaneous Multi-Marker Detection: The microarray platform's ability to interrogate nearly 100 genetic markers in a single assay is a major leap from traditional, single-target methods. This allows for a holistic view of a bacterium's genetic profile.
  • VBNC Detection Breakthrough: The adaptation of the microarray to detect expressed mRNA from VBNC bacteria is a significant advancement. It provides a way to assess the risk posed by these "invisible" pathogens, which are missed by culture-based methods.
  • Genotype-Phenotype Correlation: The study demonstrated good concordance between detected antimicrobial resistance genes (genotype) and observed resistance phenotypes, though some discrepancies highlight the complexity of resistance mechanisms.
  • Discovery of Novel Genetic Assemblages: The microarray identified unexpected genetic combinations in Vibrio species, such as type III secretion system (TTSS) genes in V. mimicus, which had not been previously reported. This highlights the power of the method for uncovering genetic diversity.

Key Results

  • High Concordance: The microarray-based identification showed excellent concordance (up to 100%) with traditional species and serotype identification methods for most tested Vibrio isolates.
  • Detection of Resistance and Virulence Genes: The platform successfully identified genes associated with antimicrobial resistance (e.g., SXT constins, class I integrons) and common virulence factors (e.g., cholera toxin genes, TTSS genes) in pathogenic Vibrio species.
  • VBNC Expression Confirmed: The study successfully detected mRNA expression of virulence genes (like ctxAB, rtxA, hlyA, tl, tdh, vvhA) in VBNC V. cholerae, V. parahaemolyticus, and V. vulnificus, indicating that these bacteria retain their pathogenic potential even when nonculturable.

Limitations and Future Work

  • Phenotypic Discrepancies: While genotypic detection of antimicrobial resistance genes was largely accurate, some drug efflux genes detected by the microarray did not always correlate with observed phenotypic resistance, suggesting the need for further investigation into these mechanisms.
  • VBNC Expression Nuances: The study acknowledges that while detecting mRNA in VBNC bacteria confirms their presence and potential, it doesn't fully explain the physiological state or the precise regulation of gene expression. Future work using whole-genome expression profiling over time is suggested to understand the VBNC state more deeply.
  • Broader Application: The authors suggest that this microarray-based approach could be valuable for monitoring natural environments, assessing the effectiveness of food processing methods (like cold pasteurization), and improving epidemiological surveillance of Vibrio infections.

Summary updated

Abstract

The morbidity and mortality associated with Vibrio-mediated waterborne diseases necessitates the development of sensitive detection technologies that are able to elucidate the identity, potential pathogenicity, susceptibility, and viability of contaminating bacteria in a timely manner. For this purpose, we have designed a single multiplex PCR assay to simultaneously amplify 95 diagnostic regions (encompassing species/serogroup-specific, antimicrobial resistance, and known toxin markers) and combined it with a long oligonucleotide microarray to create a platform capable of rapidly detecting and discriminating the major human pathogenic species from the genus Vibrio: V. cholerae, V. parahaemolyticus, V. vulnificus, and V. mimicus. We were able to validate this strategy by testing 100 geographically and temporally distributed isolates and observed an excellent concordance between species- and serotype-level microarray-based identification and traditional typing methods. In addition to accurate identification, the microarray simultaneously provided evidence of antibiotic resistance genes and mobile genetic elements, such as sulfamethoxazole-trimethoprim constins and class I integrons, and common toxin (ctxAB, rtxA, hap, hlyA, tl, tdh, trh, vvhA, vlly, and vmhA) and pathogenicity (tcpA, type III secretion system) genes that are associated with pathogenic Vibrio. The versatility of this method was further underscored by its ability to detect the expression of known toxin and virulence genes from potentially harmful viable but nonculturable organisms. The results suggest that this molecular identification method provides rapid and definitive information that would be of value in epidemiological, environmental, and health risk assessment surveillance.
BibTeX
@inproceedings{vora2005microarray,
  author = {Gary J. Vora and Carolyn E. Meador and Michele M. Bird and Cheryl A. Bopp and Joanne D. Andreadis and David A. Stenger},
  title = {{Microarray-based detection of genetic heterogeneity, antimicrobial resistance, and the viable but nonculturable state in human pathogenic <i>Vibrio spp.</i>}},
  booktitle = {Proceedings of the National Academy of Sciences},
  year = {2005},
  doi = {10.1073/pnas.0505033102},
}
Figure